BEACONPHAR Stock Overview
Engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Beacon Pharmaceuticals PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳138.90 |
| 52 Week High | ৳288.90 |
| 52 Week Low | ৳133.60 |
| Beta | -0.35 |
| 11 Month Change | -10.33% |
| 3 Month Change | -26.86% |
| 1 Year Change | -43.31% |
| 33 Year Change | -31.58% |
| 5 Year Change | 488.56% |
| Change since IPO | 60.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| BEACONPHAR | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -2.1% | -0.5% | -0.5% |
| 1Y | -43.3% | -18.2% | -20.4% |
Return vs Industry: BEACONPHAR underperformed the BD Pharmaceuticals industry which returned -19.5% over the past year.
Return vs Market: BEACONPHAR underperformed the BD Market which returned -21.5% over the past year.
Price Volatility
| BEACONPHAR volatility | |
|---|---|
| BEACONPHAR Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in BD Market | 7.4% |
| 10% least volatile stocks in BD Market | 3.6% |
Stable Share Price: BEACONPHAR's share price has been volatile over the past 3 months.
Volatility Over Time: BEACONPHAR's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 3,872 | Mohammad Karim | www.beaconpharma.com.bd |
Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, chronic care, and biotech products. It also provides various therapeutic products that include anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, muscle relaxant, anti-histamine, analgesics, and NSAIDS, as well as norepinephrine injection, anticoagulant, pain killer, antiemetic, antibiotic, calcium supplement, hyper acidity, etc. In addition, the company offers contract and toll manufacturing services.
Beacon Pharmaceuticals PLC Fundamentals Summary
| BEACONPHAR fundamental statistics | |
|---|---|
| Market cap | ৳32.09b |
| Earnings (TTM) | ৳465.98m |
| Revenue (TTM) | ৳9.89b |
68.9x
P/E Ratio3.2x
P/S RatioIs BEACONPHAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BEACONPHAR income statement (TTM) | |
|---|---|
| Revenue | ৳9.89b |
| Cost of Revenue | ৳4.91b |
| Gross Profit | ৳4.99b |
| Other Expenses | ৳4.52b |
| Earnings | ৳465.98m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.02 |
| Gross Margin | 50.42% |
| Net Profit Margin | 4.71% |
| Debt/Equity Ratio | 165.4% |
How did BEACONPHAR perform over the long term?
See historical performance and comparison